Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy (CANTAB)
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy at Pre-Treatment, Post-Treatment, at Six Month Follow-Up, and Long-Term Follow-Ups
Sponsor: National Cancer Institute (NCI)
This observational or N/A phase trial investigates Breast Cancer and Lymphoma and is currently ongoing. National Cancer Institute (NCI) leads this study, which shows 22 recorded versions since 2011 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
22 versions recorded-
Apr 28, 2026 — Present [daily]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
-
Feb 2026 — Apr 2026 [monthly]
Enrolling By Invitation
-
Apr 2025 — Feb 2026 [monthly]
Enrolling By Invitation
-
Sep 2024 — Apr 2025 [monthly]
Enrolling By Invitation
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation
▶ Show 17 earlier versions
-
May 2024 — Jul 2024 [monthly]
Enrolling By Invitation
-
Jun 2023 — May 2024 [monthly]
Enrolling By Invitation
-
Jun 2022 — Jun 2023 [monthly]
Enrolling By Invitation
-
Dec 2021 — Jun 2022 [monthly]
Enrolling By Invitation
-
Sep 2021 — Dec 2021 [monthly]
Enrolling By Invitation
Status: Active Not Recruiting → Enrolling By Invitation
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Apr 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
Dec 2019 — Apr 2020 [monthly]
Active Not Recruiting
-
Mar 2019 — Dec 2019 [monthly]
Active Not Recruiting
-
Nov 2018 — Mar 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Jun 2017 [monthly]
Recruiting NA
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
Cognitive impairments in cancer patients represent an important clinical problem. Studies to date estimating prevalence of difficulties in memory, executive function, and attention deficits have been limited by small sample sizes and many have lacked healthy control groups. More information is needed on promising biomarkers and allelic variants that may help to determine the etiology of impairment, identify those most vulnerable to impairment, and develop interventions for these difficulties. This is a longitudinal observational study of cognitive function in breast cancer and lymphoma patients receiving chemotherapy to better understand the prevalence of cognitive difficulties (i.e., problems with memory, executive function, and attention) in these populations.
Contact Information
- National Cancer Institute (NCI)
- University of Rochester NCORP Research Base
For direct contact, visit the study record on ClinicalTrials.gov .